AstraZeneca Settles Crestor Patent Dispute

25.03.2013 - AstraZeneca has seen off a remaining threat to its top-selling cholesterol drug Crestor by settling a U.S. legal case with Watson Laboratories, a unit of Actavis, and Egis. The...